When does Wegovy’s patent protection expire for Novo Nordisk?
Wegovy (semaglutide 2.4 mg) is protected by multiple overlapping patents covering different aspects such as the active ingredient, formulation/dose, and method of use. Because patent life varies by filing date, jurisdiction, and any patent-term extensions, the exact “patent expiry” depends on which specific patent family is being asked about.
DrugPatentWatch.com tracks patent status across jurisdictions and is one of the most direct ways to check which Wegovy patents are still listed and which have already expired or are expected to expire later. [1]
Why “patent expiry” can differ from “when cheaper copies can launch”
Even if a patent expires in a given country, exclusivity and regulatory protections can still delay competition. That means:
- The first launch of a generic or biosimilar can happen later than the first patent expiry date if exclusivity periods or other patents remain.
- Other listed patents (for formulation, dosing, or specific use) can block entry even after earlier patents lapse.
DrugPatentWatch.com’s patent-by-patent listings help distinguish “a patent ended” from “entry is now allowed.” [1]
What countries matter for Novo Nordisk’s Wegovy patent expiry
Patent expiry is jurisdiction-specific. A date shown for one market (for example, the U.S.) might not match expiry in the EU or the UK, because patent filings and any term extensions differ by region.
To get the most accurate expiry timing for the market you care about, use DrugPatentWatch.com’s country filters and look at the remaining active patent list for Wegovy. [1]
Can competitors enter before all Wegovy patents expire?
Often, partial entry is possible depending on what the competitor is trying to make and what is still protected. For example, companies may face barriers if their product or method infringes:
- formulation or delivery patents,
- dosing/titration or administration method patents,
- or other method-of-use claims.
The practical “could launch” date may therefore be later than the earliest stated patent expiry. Tracking multiple patents in the same product family is key. [1]
Where to check Novo Nordisk Wegovy patent status by country
For a current view of which Wegovy patents are listed as expiring and which are still active, check:
- DrugPatentWatch.com Wegovy patent pages and expiry timeline tracking. [1]
---
Sources
[1] https://www.drugpatentwatch.com/p/wegovy